Skip to main content
TipRanks
Go Ultimate75% OFF

Ildong Pharmaceutical Co., Ltd. (249420) Ratios

Ildong Pharmaceutical Co., Ltd. Ratios

KR:249420's free cash flow for Q3 2026 was ₩12.49B. For the 2026 fiscal year, KR:249420's free cash flow was decreased by ₩-2.50B and operating cash flow was ₩14.99B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.960.900.680.890.83
Quick Ratio0.530.580.440.580.60
Cash Ratio0.280.260.150.160.37
Solvency Ratio0.150.05-0.12-0.25-0.13
Operating Cash Flow Ratio0.080.10-0.11-0.17-0.03
Short-Term Operating Cash Flow Coverage0.160.22-0.19-0.38-0.09
Net Current Asset Valueâ‚© -111.55Bâ‚© -182.99Bâ‚© -201.31Bâ‚© -175.55Bâ‚© -246.84B
Leverage Ratios
Debt-to-Assets Ratio0.260.350.350.320.32
Debt-to-Equity Ratio0.611.281.251.091.48
Debt-to-Capital Ratio0.380.560.560.520.60
Long-Term Debt-to-Capital Ratio0.010.260.020.080.28
Financial Leverage Ratio2.333.663.613.434.64
Debt Service Coverage Ratio0.250.22-0.19-0.68-0.43
Interest Coverage Ratio1.420.73-3.63-7.49-5.15
Debt to Market Cap0.100.550.400.220.24
Interest Debt Per Share5409.728005.908414.758257.509952.15
Net Debt to EBITDA2.143.97-3.11-1.93-0.89
Profitability Margins
Gross Profit Margin37.88%37.96%34.55%37.06%39.18%
EBIT Margin3.06%1.24%-13.24%-17.25%-23.32%
EBITDA Margin7.04%5.46%-8.53%-12.62%-18.09%
Operating Profit Margin3.06%2.13%-8.89%-11.50%-9.71%
Pretax Profit Margin5.61%-1.74%-15.69%-18.79%-25.21%
Net Profit Margin4.88%-0.74%-13.14%-22.29%-17.80%
Continuous Operations Profit Margin4.18%-2.02%-13.48%-22.29%-18.03%
Net Income Per EBT86.99%42.80%83.72%118.65%70.61%
EBT Per EBIT183.60%-81.50%176.48%163.40%259.66%
Return on Assets (ROA)4.83%-0.78%-12.91%-21.68%-14.06%
Return on Equity (ROE)11.23%-2.85%-46.55%-74.34%-65.21%
Return on Capital Employed (ROCE)5.06%4.19%-20.18%-21.60%-15.77%
Return on Invested Capital (ROIC)2.79%2.96%-10.02%-15.03%-8.11%
Return on Tangible Assets5.08%-0.83%-13.87%-23.36%-15.52%
Earnings Yield2.39%-1.39%-16.25%-19.88%-12.48%
Efficiency Ratios
Receivables Turnover10.488.689.0710.289.77
Payables Turnover7.378.017.838.718.89
Inventory Turnover3.504.344.654.094.13
Fixed Asset Turnover2.572.782.342.502.26
Asset Turnover0.991.040.980.970.79
Working Capital Turnover Ratio-29.86-8.80-8.28-13.17-78.03
Cash Conversion Cycle89.5280.6372.1782.9284.76
Days of Sales Outstanding34.8442.0540.2635.5037.35
Days of Inventory Outstanding104.1984.1478.5589.3588.48
Days of Payables Outstanding49.5045.5646.6441.9241.07
Operating Cycle139.02126.19118.81124.85125.82
Cash Flow Ratios
Operating Cash Flow Per Share630.951012.92-1354.62-2032.37-477.86
Free Cash Flow Per Share176.60509.82-2027.52-2776.57-1309.91
Dividend Paid and CapEx Coverage Ratio1.392.00-2.00-2.71-0.57
Capital Expenditure Coverage Ratio1.392.01-2.01-2.73-0.57
Operating Cash Flow Coverage Ratio0.130.14-0.17-0.26-0.05
Operating Cash Flow to Sales Ratio0.030.05-0.06-0.08-0.02
Free Cash Flow Yield0.46%4.33%-11.28%-10.23%-3.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio40.87-71.93-6.15-5.03-8.02
Price-to-Sales (P/S) Ratio2.040.530.811.121.43
Price-to-Book (P/B) Ratio4.692.052.863.745.23
Price-to-Free Cash Flow (P/FCF) Ratio218.0123.09-8.86-9.78-25.65
Price-to-Operating Cash Flow Ratio61.0211.62-13.27-13.36-70.31
Price-to-Earnings Growth (PEG) Ratio-0.060.760.13-0.18-0.01
Enterprise Value Multiple31.1213.76-12.59-10.82-8.78
Enterprise Value1.24T462.04B645.20B870.84B889.75B
EV to EBITDA31.1213.76-12.59-10.82-8.78
EV to Sales2.190.751.071.371.59
EV to Free Cash Flow234.1232.45-11.77-11.91-28.56
EV to Operating Cash Flow65.5316.33-17.62-16.27-78.28
Tangible Book Value Per Share7015.214464.364889.195735.783950.29
Shareholders’ Equity Per Share8204.505755.346272.397259.486428.78
Tax and Other Ratios
Effective Tax Rate0.25-0.160.14-0.190.28
Revenue Per Share18875.7722015.6422225.6024207.2023549.78
Net Income Per Share921.07-163.83-2920.02-5396.66-4191.94
Tax Burden0.870.430.841.190.71
Interest Burden1.84-1.401.191.091.08
Research & Development to Revenue0.060.080.160.170.17
SG&A to Revenue0.140.150.140.170.17
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.69-2.280.460.380.11

Currency in KRW